Galectin Therapeutics (GALT) Accumulated Depreciation (2011 - 2024)
Galectin Therapeutics (GALT) posted quarterly Accumulated Depreciation of $74000.0 for Q4 2024, little changed year-over-year from $74000.0 in Q1 2024, and little changed quarter-over-quarter from $74000.0 in Q4 2023.
Galectin Therapeutics (GALT) Accumulated Depreciation (2011 - 2024) Analysis & Trends
Galectin Therapeutics' Accumulated Depreciation history runs 12 years deep, the most recent figure standing at $74000.0 for Q4 2024.
- In Q4 2024, Accumulated Depreciation changed 0.0% year-over-year to $74000.0; the TTM figure through Dec 2024 stood at $74000.0 (changed 0.0% YoY), while the FY2024 annual figure was $74000.0, changed 0.0% from the prior year.
- Accumulated Depreciation for Q4 2024 stood at $74000.0, roughly flat from $74000.0 in the prior quarter.
- The five-year high for Accumulated Depreciation was $74000.0 in Q4 2020, with the low at $74000.0 in Q4 2020.
- The 5-year median for Accumulated Depreciation is $74000.0 (2020), against an average of $74000.0.
- Peak annual rise in Accumulated Depreciation reached 0.0% in 2021, while the deepest fall reached 0.0% in 2021.
- Galectin Therapeutics' Accumulated Depreciation stood at $74000.0 in 2020, then changed by 0.0% to $74000.0 in 2021, then changed by 0.0% to $74000.0 in 2022, then changed by 0.0% to $74000.0 in 2023, then changed by 0.0% to $74000.0 in 2024.
- Business Quant data shows GALT's Accumulated Depreciation at $74000.0 in Q4 2024, $74000.0 in Q4 2023, and $74000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Galectin Therapeutics | 226.55 Mn | 226.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 74,000.00 |
| Dec 31, 2023 | 74,000.00 |
| Dec 31, 2022 | 74,000.00 |
| Dec 31, 2021 | 74,000.00 |
| Dec 31, 2020 | 74,000.00 |
| Dec 31, 2017 | 74,000.00 |
| Dec 31, 2016 | 74,000.00 |
| Dec 31, 2015 | 74,000.00 |
| Dec 31, 2014 | 73,000.00 |
| Dec 31, 2013 | 71,000.00 |
| Dec 31, 2012 | 66,000.00 |
| Dec 31, 2011 | 315,000.00 |